ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.96308
0.11%
Brent Oil
84.065
0.63%
Bitcoin
57,700.76
-0.92%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) Noticias

CGEN Compugen Ltd

1.99
0.00 (0.00%)
Pre Mercado
Última actualización: 03:00:01
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Compugen Ltd CGEN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.99 03:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.99
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:00PRNUSCompugen to Present New Clinical Data Showing COM701 Triple..
10/4/202406:00PRNUSCompugen Publishes Paper in Cancer Immunology Research..
03/4/202406:00PRNUSCompugen to Participate in Two Upcoming Investor Conferences
11/3/202406:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
06/3/202406:00PRNUSCompugen to Present Data Reflecting its Diversified..
05/3/202415:06EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202406:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
05/3/202405:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
26/2/202406:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
20/2/202406:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
15/2/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202406:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
08/1/202406:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202406:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
08/1/202406:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
19/12/202308:30APSStrong Open For Biotech Following Exclusive Agreement..
19/12/202306:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202306:10PRNUSCompugen will be Eligible to Receive $10 Million Milestone..
19/12/202306:05PRNUSCompugen to Host Conference Call to Discuss Exclusive..
19/12/202306:00BWGilead and Compugen Announce Exclusive License Agreement for..
07/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:00PRNUSCompugen Reports Third Quarter 2023 Results
06/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202306:00PRNUSCompugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity..
03/11/202315:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202315:35PRNUSCompugen Announces Receipt of Nasdaq Minimum Bid Price..
31/10/202308:00PRNUSCompugen to Present New Data at SITC 2023 Suggesting Leading..
24/10/202306:00PRNUSCompugen to Release Third Quarter 2023 Results on Tuesday,..
03/10/202306:00PRNUSCompugen to Present at Single Cell Genomics 2023 Meeting
02/10/202306:00PRNUSCompugen Expands Intellectual Property with New Japanese..
27/9/202308:00PRNUSCompugen to Present New Clinical and Pre-Clinical Data in..
21/9/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/8/202306:00PRNUSCompugen to Present at the H.C. Wainwright 25th Annual..
23/8/202307:00EDGAR2Form 20-F/A - Annual and transition report of foreign..
07/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202306:00PRNUSCompugen Reports Second Quarter 2023 Results
24/7/202306:00PRNUSCompugen to Release Second Quarter 2023 Results on Monday,..
17/7/202306:00PRNUSCompugen Wins on PVRIG European Patent Opposition Pursued by..
22/6/202306:00PRNUSCompugen Doses First Patient in Triple Immunotherapy..
13/6/202306:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
05/6/202306:00PRNUSCompugen's COM701 (anti-PVRIG) Demonstrates Preliminary..
15/5/202306:00PRNUSCompugen Reports First Quarter 2023 Results
11/5/202306:00PRNUSCompugen to Host DNAM-1 Axis Virtual Investor Event with KOL..
09/5/202306:00PRNUSCompugen to Present at the JMP Securities Life Sciences..

Su Consulta Reciente

NASDAQ
CGEN
Compugen
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados